Bone Loss Active Not Recruiting Phase 4 Trials for Risedronic acid (DB00884)

Also known as: Osteopenia / Osteopaenia

IndicationStatusPhase
DBCOND0031952 (Bone Loss)Active Not Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03411902Weight Loss With Risedronate for Bone HealthSupportive Care